Hopefully they get Chloroquine trials up fast, preferably
Hopefully they get Chloroquine trials up fast, preferably as a Phase 4.
Something like Chloroquine, even if it's not the best long-term option, would be critical to greatly reducing the mortality rate and keeping our healthcare workers in the fight.
Additionally, if the mortality rate can be blunted considerably by this drug, life can hopefully return to normal and we may be able to avoid lasting economic devastation.
Eagerly awaiting test results on Brilacidin and other candidates as well.
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Pacaso's Recent Success on Kiawah Island Pacaso, a leader in the co-ownership real estate market, has announced an impressive accomplishment on Kiawah Island. Their latest offering, Sea Marsh, achieved a full sellout before its public debut, showcasing a notable demand for luxury co-ownership in coastal areas. This rapid sellout highlights the appeal and potential of...
Continue Reading
Growth of the Cataract Surgery Complications Market The cataract surgery complications market is set to grow steadily, propelled by advancements in treatment options, improved diagnostic methods, and heightened awareness among patients and healthcare professionals. This market promises a bright future as new drugs are developed and the number of reported cases rises with...
Continue Reading
CloudPaths Teams Up with JWMI for Employee Development CloudPaths, known for its expertise in digital transformation, has established an exciting partnership with the Jack Welch Management Institute (JWMI) at Strayer University. This collaboration aims to provide selected employees with employer-funded access to an advanced Master of Business Administration (MBA) program....
Continue Reading
Revolutionary Developments in Wireless Charging Technology The latest advancements in wireless charging technology have taken a significant leap forward thanks to research conducted at Incheon National University. The development of a new resonant, auto-adjusting rectifier aims to boost the efficiency of wireless power systems by adapting dynamically to frequency...
Continue Reading
Clarivate Achieves Recognition in WTR 1000 for 2025 Highly recommended in trademark management, searching and watching, renewals and recordals Clarivate Plc (NYSE: CLVT), a global leader in transformative intelligence, has gained notable recognition in the World Trademark Review 1000 for the year 2025. This esteemed guide features the top professionals and firms in the...
Continue Reading
